AzPA Town Hall!

AzPA Pharmacy Flash

• Digital Tools Enhance Specialty Drug Adherence
  As patient assistance programs become more complex, various technology solutions have been developed to assist patients in navigating these services. These platforms provide automated enrollment, progress and savings tracking and educational resources.
• FDA Approves Chronic Spontaneous Urticaria Drug, Rhapsido
  The FDA has approved Rhapsido , the first oral Bruton’s tyrosine kinase inhibitor for chronic spontaneous urticaria in adults. It functions by inhibiting the Bruton’s tyrosine kinase protein, believed to trigger chronic spontaneous urticaria flares, which manifest as red, swollen and itchy hives.
• Pharmacists Can Provide Trusted Medical Advice in an Era of Fractured Health Care
  This American Pharmacists Month highlights a fractured health care system due to a new administration's significant changes, which include altering vaccine access, reducing health insurance funding and revisiting issues with established medications.